Shoulder Innovations, Inc.

Shoulder Innovations, Inc. is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. The company, initially formed in 2009 as Shoulder Innovations, LLC, converted to a C-corporation and changed its name to Shoulder Innovations, Inc. on February 10, 2017. Its mission is to revolutionize shoulder arthroplasty by providing implants that offer enhanced stability and longevity, adopting a patient-centric approach to improve the quality of life for individuals with severe shoulder conditions. The company's principal executive offices are located in Grand Rapids, Michigan, United States.

Shoulder Innovations offers advanced implant systems for shoulder arthroplasty, including the InSet Total Shoulder Arthroplasty and InSet Reverse Shoulder Arthroplasty systems. A core element of its ecosystem is the patented InSet™ Glenoid technology, designed to address glenoid loosening, a primary cause of failure in shoulder replacement surgery. The company also provides the ProVoyance Shoulder Planning Software, an AI-powered tool that translates CT images into 3D bone models for surgical planning, alongside efficient instrument systems like the InSet Tray System, enabling technologies, and specialized support.

Under the leadership of CEO & Executive Chairman Rob Ball, Shoulder Innovations has recently reported strong financial performance, with first-quarter 2026 net revenue reaching $16.7 million, a 65% year-over-year increase, and has raised its 2026 net revenue outlook to $65–$68 million. The company initiated the full commercial launch of its InSet™ I-135RFX Humeral Stem on April 27, 2026. In December 2025, Shoulder Innovations announced a strategic partnership with Interventional Systems (INS) to develop a shoulder-specific micro-robotic platform that will integrate with its ProVoyance system, aiming to enhance surgical precision and efficiency.